ESG Inc. (ESGH) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
523 SCHOOL HOUSE RD KENNETT SQUARE, PA 19348 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 8/31/2023 | 8/31/2022 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 86,139 | |||
| Cash and cash equivalents | 86,139 | |||
| Short-term investments | ||||
| Total current assets: | 86,139 | |||
| Noncurrent Assets | ||||
| Property, plant and equipment | 1,029 | |||
| Total noncurrent assets: | 1,029 | |||
| TOTAL ASSETS: | 87,168 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,366 | |||
| Accounts payable | 3,366 | |||
| Total current liabilities: | 3,366 | |||
| Noncurrent Liabilities | ||||
| Total liabilities: | 3,366 | |||
| Equity | ||||
| Equity, attributable to parent | 83,802 | |||
| Common stock | 15,467 | |||
| Additional paid in capital | 124,700 | |||
| Accumulated deficit | (56,365) | |||
| Total equity: | 83,802 | |||
| TOTAL LIABILITIES AND EQUITY: | 87,168 | |||
Income Statement (P&L) (USD)
| 8/31/2023 | 8/31/2022 | ||
|---|---|---|---|
| Operating expenses | (54,953) | ||
| Operating loss: | (54,953) | ||
| Loss from continuing operations before equity method investments, income taxes: | (54,953) | ||
| Other undisclosed income from continuing operations before income taxes | 40 | ||
| Loss from continuing operations before income taxes: | (54,913) | ||
| Income tax expense | |||
| Loss from continuing operations: | (54,913) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (54,913) | |
| Other undisclosed net income | |||
| Net loss attributable to parent: | (54,913) | ||
| Other undisclosed net income available to common stockholders, basic | 109,826 | ||
| Net income (loss) available to common stockholders, diluted: | 54,913 | ||
Comprehensive Income (USD)
| 8/31/2023 | 8/31/2022 | ||
|---|---|---|---|
| Net loss: | (54,913) | ||
| Comprehensive loss, net of tax, attributable to parent: | (54,913) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.